Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice.

Capulli M, Costantini R, Sonntag S, Maurizi A, Paganini C, Monti L, Forlino A, Shmerling D, Teti A, Rossi A.

PLoS One. 2019 Mar 13;14(3):e0213660. doi: 10.1371/journal.pone.0213660. eCollection 2019.

2.

Low complication rates in Minimally Invasive Plate Osteosynthesis (MIPO) for proximal humeral fractures at 5 years of follow-up.

Falez F, Papalia M, Carbone S, Teti A, Favetti F, Panegrossi G, Casella F, Mazzotta G.

Injury. 2019 Feb 2. pii: S0020-1383(19)30042-7. doi: 10.1016/j.injury.2019.01.042. [Epub ahead of print]

PMID:
30799100
3.

Isolation and Generation of Osteoclasts.

Rucci N, Zallone A, Teti A.

Methods Mol Biol. 2019;1914:3-19. doi: 10.1007/978-1-4939-8997-3_1.

PMID:
30729457
4.

Risk Profiles for Care Dependency: Cross-Sectional Findings of a Population-Based Cohort Study in Germany.

Schnitzer S, Blüher S, Teti A, Schaeffner E, Ebert N, Martus P, Suhr R, Kuhlmey A.

J Aging Health. 2019 Jan 18:898264318822364. doi: 10.1177/0898264318822364. [Epub ahead of print]

PMID:
30658538
5.

Osteoblasts Regulate Angiogenesis in Response to Mechanical Unloading.

Veeriah V, Paone R, Chatterjee S, Teti A, Capulli M.

Calcif Tissue Int. 2019 Mar;104(3):344-354. doi: 10.1007/s00223-018-0496-z. Epub 2018 Nov 21.

PMID:
30465120
6.

Apoptosis-associated speck-like protein containing a caspase-1 recruitment domain (ASC) contributes to osteoblast differentiation and osteogenesis.

Sartoretto S, Gemini-Piperni S, da Silva RA, Calasans MD, Rucci N, Pires Dos Santos TM, Lima IBC, Rossi AM, Alves G, Granjeiro JM, Teti A, Zambuzzi WF.

J Cell Physiol. 2019 Apr;234(4):4140-4153. doi: 10.1002/jcp.27226. Epub 2018 Aug 31.

PMID:
30171612
7.

[A critical analysis of the degree of care humanization in the Hospitals of the Provincia Romana San Giovanni di Dio Fatebenefratelli (FBF)].

Verginelli F, Gallo R, Teti A, Franco C, Piscioneri P, Pimpinella G, Fiore R, Primavera A, Sorrentino A, Guglielmucci G, Venditti M, Carbone A, Iannuzzo M, Seroni G, Civello P, Cardarelli M, Roberti G.

Ig Sanita Pubbl. 2018 Jan-Feb;74(1):9-24. Italian.

PMID:
29734319
8.

Congenital disorders of bone and blood.

Teti A, Teitelbaum SL.

Bone. 2019 Feb;119:71-81. doi: 10.1016/j.bone.2018.03.002. Epub 2018 Mar 6. Review.

PMID:
29522883
9.

RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development.

Maurizi A, Capulli M, Patel R, Curle A, Rucci N, Teti A.

Bone. 2018 May;110:343-354. doi: 10.1016/j.bone.2018.02.031. Epub 2018 Mar 6.

PMID:
29501587
10.

A Complex Role for Lipocalin 2 in Bone Metabolism: Global Ablation in Mice Induces Osteopenia Caused by an Altered Energy Metabolism.

Capulli M, Ponzetti M, Maurizi A, Gemini-Piperni S, Berger T, Mak TW, Teti A, Rucci N.

J Bone Miner Res. 2018 Jun;33(6):1141-1153. doi: 10.1002/jbmr.3406. Epub 2018 Mar 24.

PMID:
29444358
11.

Osteomimicry: How the Seed Grows in the Soil.

Rucci N, Teti A.

Calcif Tissue Int. 2018 Feb;102(2):131-140. doi: 10.1007/s00223-017-0365-1. Epub 2017 Nov 16. Review.

PMID:
29147721
12.

Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone.

Cappariello A, Loftus A, Muraca M, Maurizi A, Rucci N, Teti A.

J Bone Miner Res. 2018 Mar;33(3):517-533. doi: 10.1002/jbmr.3332. Epub 2017 Dec 11.

13.

[What potential do geographic information systems have for population-wide health monitoring in Germany? : Perspectives and challenges for the health monitoring of the Robert Koch Institute].

Thißen M, Niemann H, Varnaccia G, Rommel A, Teti A, Butschalowsky H, Manz K, Finger JD, Kroll LE, Ziese T.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Dec;60(12):1440-1452. doi: 10.1007/s00103-017-2652-4. Review. German.

PMID:
29075811
14.

[Regionalization of federal health reporting using the example of diabetes surveillance : Aims and results of the discussion between the Robert Koch Institute and the federal states].

Gabrys L, Heidemann C, Teti A, Borrmann B, Gawrich S, Maulbecker-Armstrong C, Fertmann R, Schubert U, Schmidt C, Baumert J, Paprott R, Du Y, Scheidt-Nave C, Ziese T.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Oct;60(10):1147-1152. doi: 10.1007/s00103-017-2616-8. German.

PMID:
28871413
15.

Non-conventional role of haemoglobin beta in breast malignancy.

Ponzetti M, Capulli M, Angelucci A, Ventura L, Monache SD, Mercurio C, Calgani A, Sanità P, Teti A, Rucci N.

Br J Cancer. 2017 Sep 26;117(7):994-1006. doi: 10.1038/bjc.2017.247. Epub 2017 Aug 3.

16.

[Integration of secondary data into national diabetes surveillance : Background, aims and results of the secondary data workshop at the Robert Koch Institute].

Schmidt C, Bätzing-Feigenbaum J, Bestmann A, Brinks R, Dreß J, Goffrier B, Hagen B, Laux G, Pollmanns J, Schröder H, Stahl T, Baumert J, Du Y, Gabrys L, Heidemann C, Paprott R, Scheidt-Nave C, Teti A, Ziese T.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Jun;60(6):656-661. doi: 10.1007/s00103-017-2552-7. Review. German.

PMID:
28466131
17.

Osteopetroses, emphasizing potential approaches to treatment.

Teti A, Econs MJ.

Bone. 2017 Sep;102:50-59. doi: 10.1016/j.bone.2017.02.002. Epub 2017 Feb 4. Review.

18.

Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk.

Veeriah V, Zanniti A, Paone R, Chatterjee S, Rucci N, Teti A, Capulli M.

Sci Rep. 2016 Jul 19;6:29880. doi: 10.1038/srep29880.

19.

The "love-hate" relationship between osteoclasts and bone matrix.

Rucci N, Teti A.

Matrix Biol. 2016 May-Jul;52-54:176-190. doi: 10.1016/j.matbio.2016.02.009. Epub 2016 Feb 26. Review.

PMID:
26921625
20.

Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate.

Thaler R, Maurizi A, Roschger P, Sturmlechner I, Khani F, Spitzer S, Rumpler M, Zwerina J, Karlic H, Dudakovic A, Klaushofer K, Teti A, Rucci N, Varga F, van Wijnen AJ.

J Biol Chem. 2016 Mar 25;291(13):6754-71. doi: 10.1074/jbc.M115.678235. Epub 2016 Jan 12.

21.

Minimally invasive plate osteosynthesis in proximal humeral fractures: one-year results of a prospective multicenter study.

Falez F, Papalia M, Greco A, Teti A, Favetti F, Panegrossi G, Casella F, Necozione S.

Int Orthop. 2016 Mar;40(3):579-85. doi: 10.1007/s00264-015-3069-z. Epub 2015 Dec 19.

PMID:
26686493
22.

P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.

Sinadinos A, Young CN, Al-Khalidi R, Teti A, Kalinski P, Mohamad S, Floriot L, Henry T, Tozzi G, Jiang T, Wurtz O, Lefebvre A, Shugay M, Tong J, Vaudry D, Arkle S, doRego JC, Górecki DC.

PLoS Med. 2015 Oct 13;12(10):e1001888. doi: 10.1371/journal.pmed.1001888. eCollection 2015 Oct.

23.

Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2.

Capulli M, Maurizi A, Ventura L, Rucci N, Teti A.

Mol Ther Nucleic Acids. 2015 Sep 1;4:e248. doi: 10.1038/mtna.2015.21.

24.

Feasibility of the Factorial Survey Method in Aging Research: Consistency Effects Among Older Respondents.

Teti A, Gross C, Knoll N, Blüher S.

Res Aging. 2016 Oct;38(7):715-41. doi: 10.1177/0164027515600767. Epub 2015 Aug 17.

PMID:
26282570
25.

Gut microbiota-derived outer membrane vesicles: under-recognized major players in health and disease?

Muraca M, Putignani L, Fierabracci A, Teti A, Perilongo G.

Discov Med. 2015 May;19(106):343-8. Review.

26.

Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation.

Cappariello A, Paone R, Maurizi A, Capulli M, Rucci N, Muraca M, Teti A.

Biomaterials. 2015 Apr;46:58-69. doi: 10.1016/j.biomaterials.2014.12.033. Epub 2015 Jan 17.

27.

The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: a preclinical study.

Rucci N, Capulli M, Olstad OK, Önnerfjord P, Tillgren V, Gautvik KM, Heinegård D, Teti A.

Cancer Lett. 2015 Mar 1;358(1):67-75. doi: 10.1016/j.canlet.2014.12.032. Epub 2014 Dec 18.

PMID:
25529009
28.

Reprint of: The Great Beauty of the osteoclast.

Cappariello A, Maurizi A, Veeriah V, Teti A.

Arch Biochem Biophys. 2014 Nov 1;561:13-21. doi: 10.1016/j.abb.2014.08.009. Review.

PMID:
25282390
29.

Bone, a dynamic and integrating tissue.

van der Eerden BC, Teti A, Zambuzzi WF.

Arch Biochem Biophys. 2014 Nov 1;561:1-2. doi: 10.1016/j.abb.2014.08.012. Epub 2014 Aug 23. No abstract available.

PMID:
25157441
30.

Lipocalin 2: a new mechanoresponding gene regulating bone homeostasis.

Rucci N, Capulli M, Piperni SG, Cappariello A, Lau P, Frings-Meuthen P, Heer M, Teti A.

J Bone Miner Res. 2015 Feb;30(2):357-68. doi: 10.1002/jbmr.2341.

31.

Deregulation of the IL-1β axis in chronic recurrent multifocal osteomyelitis.

Scianaro R, Insalaco A, Bracci Laudiero L, De Vito R, Pezzullo M, Teti A, De Benedetti F, Prencipe G.

Pediatr Rheumatol Online J. 2014 Jul 17;12:30. doi: 10.1186/1546-0096-12-30. eCollection 2014.

32.

The Great Beauty of the osteoclast.

Cappariello A, Maurizi A, Veeriah V, Teti A.

Arch Biochem Biophys. 2014 Sep 15;558:70-8. doi: 10.1016/j.abb.2014.06.017. Epub 2014 Jun 27. Review.

PMID:
24976175
33.

Kinome profiling of osteoblasts on hydroxyapatite opens new avenues on biomaterial cell signaling.

Gemini-Piperni S, Milani R, Bertazzo S, Peppelenbosch M, Takamori ER, Granjeiro JM, Ferreira CV, Teti A, Zambuzzi W.

Biotechnol Bioeng. 2014 Sep;111(9):1900-5. doi: 10.1002/bit.25246. Epub 2014 Jun 11.

PMID:
24668294
34.

The C-terminal domain of chondroadherin: a new regulator of osteoclast motility counteracting bone loss.

Capulli M, Olstad OK, Onnerfjord P, Tillgren V, Muraca M, Gautvik KM, Heinegård D, Rucci N, Teti A.

J Bone Miner Res. 2014 Aug;29(8):1833-46. doi: 10.1002/jbmr.2206.

35.

Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression.

Sanità P, Capulli M, Teti A, Galatioto GP, Vicentini C, Chiarugi P, Bologna M, Angelucci A.

BMC Cancer. 2014 Mar 5;14:154. doi: 10.1186/1471-2407-14-154.

36.

Mechanisms of osteoclast-dependent bone formation.

Teti A.

Bonekey Rep. 2013 Dec 4;2:449. doi: 10.1038/bonekey.2013.183.

37.

Differentially expressed genes in autosomal dominant osteopetrosis type II osteoclasts reveal known and novel pathways for osteoclast biology.

Coudert AE, Del Fattore A, Baulard C, Olaso R, Schiltz C, Collet C, Teti A, de Vernejoul MC.

Lab Invest. 2014 Mar;94(3):275-85. doi: 10.1038/labinvest.2013.140. Epub 2013 Dec 16.

38.

Recent advances in mesenchymal stem cell immunomodulation: the role of microvesicles.

Fierabracci A, Del Fattore A, Luciano R, Muraca M, Teti A, Muraca M.

Cell Transplant. 2015;24(2):133-49. doi: 10.3727/096368913X675728. Epub 2013 Nov 21. Review.

PMID:
24268069
39.

Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models.

Alam I, Gray AK, Chu K, Ichikawa S, Mohammad KS, Capannolo M, Capulli M, Maurizi A, Muraca M, Teti A, Econs MJ, Del Fattore A.

Bone. 2014 Feb;59:66-75. doi: 10.1016/j.bone.2013.10.021. Epub 2013 Nov 1.

40.

CLCN7 and TCIRG1 mutations differentially affect bone matrix mineralization in osteopetrotic individuals.

Barvencik F, Kurth I, Koehne T, Stauber T, Zustin J, Tsiakas K, Ludwig CF, Beil FT, Pestka JM, Hahn M, Santer R, Supanchart C, Kornak U, Del Fattore A, Jentsch TJ, Teti A, Schulz A, Schinke T, Amling M.

J Bone Miner Res. 2014 Apr;29(4):982-91. doi: 10.1002/jbmr.2100.

41.

[Residential mobility in old age. Age-appropriate housing as a primary preventive strategy].

Teti A, Grittner U, Kuhlmey A, Blüher S.

Z Gerontol Geriatr. 2014 Jun;47(4):320-8. German.

PMID:
23958998
42.

An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6.

Del Fattore A, Cappariello A, Capulli M, Rucci N, Muraca M, De Benedetti F, Teti A.

Osteoporos Int. 2014 Feb;25(2):681-92. doi: 10.1007/s00198-013-2479-2. Epub 2013 Aug 14.

PMID:
23943168
43.

Proline/arginine-rich end leucine-rich repeat protein N-terminus is a novel osteoclast antagonist that counteracts bone loss.

Rucci N, Capulli M, Ventura L, Angelucci A, Peruzzi B, Tillgren V, Muraca M, Heinegård D, Teti A.

J Bone Miner Res. 2013 Sep;28(9):1912-24. doi: 10.1002/jbmr.1951.

44.

Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis.

Moro F, De Simone C, Morciano A, Tropea A, Sagnella F, Palla C, Scarinci E, Teti A, Caldarola G, D'Agostino M, Mancuso S, Lanzone A, Apa R.

Fertil Steril. 2013 Mar 1;99(3):936-42. doi: 10.1016/j.fertnstert.2012.10.040. Epub 2012 Nov 16.

PMID:
23158933
45.

Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.

Capulli M, Angelucci A, Driouch K, Garcia T, Clement-Lacroix P, Martella F, Ventura L, Bologna M, Flamini S, Moreschini O, Lidereau R, Ricevuto E, Muraca M, Teti A, Rucci N.

J Bone Miner Res. 2012 Nov;27(11):2387-98. doi: 10.1002/jbmr.1686.

46.

NHERF1 acts as a molecular switch to program metastatic behavior and organotropism via its PDZ domains.

Cardone RA, Greco MR, Capulli M, Weinman EJ, Busco G, Bellizzi A, Casavola V, Antelmi E, Ambruosi B, Dell'Aquila ME, Paradiso A, Teti A, Rucci N, Reshkin SJ.

Mol Biol Cell. 2012 Jun;23(11):2028-40. doi: 10.1091/mbc.E11-11-0911. Epub 2012 Apr 11.

47.

The tight relationship between osteoclasts and the immune system.

Del Fattore A, Teti A.

Inflamm Allergy Drug Targets. 2012 Jun;11(3):181-7. Review.

PMID:
22280239
48.

Novel C16orf57 mutations in patients with Poikiloderma with Neutropenia: bioinformatic analysis of the protein and predicted effects of all reported mutations.

Colombo EA, Bazan JF, Negri G, Gervasini C, Elcioglu NH, Yucelten D, Altunay I, Cetincelik U, Teti A, Del Fattore A, Luciani M, Sullivan SK, Yan AC, Volpi L, Larizza L.

Orphanet J Rare Dis. 2012 Jan 23;7:7. doi: 10.1186/1750-1172-7-7.

49.

c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling.

Peruzzi B, Cappariello A, Del Fattore A, Rucci N, De Benedetti F, Teti A.

Nat Commun. 2012 Jan 17;3:630. doi: 10.1038/ncomms1651.

PMID:
22252554
50.

Osteoclasts and hematopoiesis.

Teti A.

Bonekey Rep. 2012 Mar 28;1:46. doi: 10.1038/bonekey.2012.46. eCollection 2012.

Supplemental Content

Support Center